Advertisement
Screener

AETHLON MEDICAL, INC. (AEMD) Shareholders' Equity

2.8 / 5 stars · 68/120 Roast Me

AETHLON MEDICAL, INC. Shareholders' Equity

AETHLON MEDICAL, INC. (AEMD) had Shareholders' Equity of $5.20 million as of 2026-06-30, per its 10-Q filed 2026-08-13.

Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent

us-gaap:StockholdersEquity · last filed 2026-08-13

  • 2026-06-30: Stockholders' Equity Attributable to Parent $5.20M.
  • 2026-03-31: Stockholders' Equity Attributable to Parent $4.89M.
  • 2025-12-31: Stockholders' Equity Attributable to Parent $6.71M.
  • 2025-09-30: Stockholders' Equity Attributable to Parent $5.75M.
Period endStockholders' Equity Attributable to ParentStockholders' Equity Attributable to Parent as first filed
2026-06-30$5.20M
10-Q · filed 2026-08-13
2026-03-31$4.89M
10-Q · filed 2026-08-13
2025-12-31$6.71M
10-Q · filed 2026-02-12
2025-09-30$5.75M
10-Q · filed 2026-02-12
2025-06-30$3.42M
10-Q · filed 2026-08-13
2025-03-31$5.12M
10-Q · filed 2026-08-13
2024-12-31$4.33M
10-Q · filed 2026-02-12
2024-09-30$6.02M
10-Q · filed 2026-02-12
2024-06-30$8.71M
10-Q · filed 2026-02-12
2024-03-31$5.77M
10-K · filed 2026-06-10
2023-12-31$7.61M
10-Q · filed 2025-02-12
2023-09-30$10.32M
10-Q · filed 2025-02-12
2023-06-30$13.11M
10-Q · filed 2025-02-12
2023-03-31$15.06M
10-K · filed 2025-06-26
$15.06M
10-K · filed 2023-06-28
2022-12-31$17.28M
10-Q · filed 2024-02-14
2022-09-30$19.87M
10-Q · filed 2024-02-14
2022-06-30$14.92M
10-Q · filed 2024-02-14
$15.06M
10-Q · filed 2022-08-09
2022-03-31$16.99M
10-K · filed 2024-06-27
$17.13M
10-K · filed 2022-06-28
2021-12-31$20.70M
10-Q · filed 2022-02-14
2021-09-30$23.04M
10-Q · filed 2021-11-09
2021-06-30$24.87M
10-Q · filed 2021-08-09
2021-03-31$9.43M
10-K · filed 2022-06-28
2020-12-31$11.57M
10-Q · filed 2021-02-10
2020-09-30$13.70M
10-Q · filed 2020-10-28
2020-06-30$15.32M
10-Q · filed 2020-08-11
2020-03-31$9.41M
10-K · filed 2021-06-24
2019-12-31$3.93M
10-Q · filed 2020-02-10
2019-09-30$149.15K
10-Q · filed 2019-11-01
2019-06-30$1.15M
10-Q · filed 2019-08-14
2019-03-31$2.43M
10-K · filed 2020-06-25
2018-12-31$3.29M
10-Q · filed 2019-02-11
2018-09-30$4.13M
10-Q · filed 2018-11-06
2018-06-30$5.22M
10-Q · filed 2018-08-08
2018-03-31$6.13M
10-K · filed 2019-07-01
2017-12-31$4.70M
10-Q · filed 2018-02-01
2017-09-30$108.87K
10-Q · filed 2017-11-02
2017-06-30-$865.33K
10-Q · filed 2017-08-10
2017-03-31$676.38K
10-K · filed 2018-06-08
2016-12-31$74.53K
10-Q · filed 2017-02-10
2016-09-30-$67.63K
10-Q · filed 2016-11-10
2016-06-30$433.34K
10-Q · filed 2016-08-11
2016-03-31$1.55M
10-K · filed 2017-06-28
2015-12-31$2.75M
10-Q · filed 2016-02-04
2015-09-30$3.90M
10-Q · filed 2015-11-16
2015-06-30$5.08M
10-Q · filed 2015-08-13
2015-03-31$615.45K
10-K · filed 2016-06-29
2014-12-31$1.22M
10-Q · filed 2015-02-10
2014-09-30-$3.42M
10-Q · filed 2014-11-10
2014-06-30-$3.69M
10-Q · filed 2014-08-14
2014-03-31-$14.95M
10-K · filed 2015-07-13
2013-12-31-$10.81M
10-Q · filed 2014-02-11
2013-09-30-$11.55M
10-Q · filed 2013-11-14
2013-06-30-$8.82M
10-Q · filed 2013-08-13
2013-03-31-$9.14M
10-K · filed 2014-07-15
2012-12-31-$7.32M
10-Q · filed 2013-02-12
2012-09-30-$8.47M
10-Q · filed 2012-11-13
2012-06-30-$8.39M
10-Q/A · filed 2012-08-28
2012-03-31-$9.30M
10-K · filed 2014-07-15
2011-12-31-$6.11M
10-Q · filed 2012-02-16
2011-09-30-$6.34M
10-Q · filed 2011-11-18
2011-06-30-$6.71M
10-Q/A · filed 2011-08-22
2011-03-31-$5.98M
10-K · filed 2013-07-15
2010-03-31-$4.40M
10-K · filed 2012-06-29

Similar stocks

Stock NameCountryMarket CapPE Ratio
Bluejay Diagnostics, Inc. (BJDX)United States$0.004B
INTELLIGENT BIO SOLUTIONS INC. (INBS)United States$0.005B
OSR Health, Inc. (OSRH)United States$0.004B-0.75
Adagio Medical Holdings, Inc. (ADGM)United States$0.004B
Autonomix Medical, Inc. (AMIX)United States$0.004B
Sonoma Pharmaceuticals, Inc. (SNOA)United States$0.006B-2.59
enVVeno Medical Corp (NVNO)United States$0.006B-0.48
Beyond Air, Inc. (XAIR)United States$0.003B-0.01
Vivos Therapeutics, Inc. (VVOS)United States$0.003B-0.26
Co-Diagnostics, Inc. (CODX)United States$0.007B-0.32